Hepatitis A vaccine inactivated - Beijing Minhai Biotechnology
Alternative Names: HAV inactivated vaccine - Beijing Minhai Biotechnology; Inactivated Hepatitis A vaccine - Beijing Minhai BiotechnologyLatest Information Update: 19 Nov 2018
At a glance
- Originator Beijing Minhai Biotechnology
- Class Hepatitis A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis A
Most Recent Events
- 19 Nov 2018 No recent reports of development identified for phase-III for Hepatitis A (Prevention) in China (Parenteral)
- 01 Sep 2015 Phase-III clinical trials in Hepatitis A (Prevention) in China (Parenteral) before September 2015